Terbutaline as a treatment for premature labour is an off-label use not approved by the FDA. It is a pregnancy category 'B' medication and is routinely prescribed to stop contractions. Terbutaline is currently on the World Anti-Doping Agency's list of prohibited drugs, except, when administered by inhalation, a Therapeutic Use Exemption (TUE) has been obtained in advance.
Terbutaline is preferred over Ritodrine because it has minimal effects on blood pressure..
FDA WARNS AGAINST CERTAIN USES OF ASTHMA DRUG TERBUTALINE FOR PRETERM LABOR CERTAIN USES COULD LEAD TO MATERNAL HEART PROBLEMS AND DEATH.
Feb 17, 2011; Silver Spring, MD -- The following information was released by the U.S. Food and Drug Administration: The U.S. Food and Drug...